Clinical Trial Update: Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous adipose-derived mesenchymal stromal cells transplantation for ultra filtration failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ultra Filtration Failure

Drugs mentioned

• Autologous Adipose-Derived Mesenchymal Stromal Cells (AD-MSC) transplantation

Snippet

Sponsor: Royan Institute | Conditions: Ultra Filtration Failure | Phase 1, Phase 2 | Status: COMPLETED